Yield10 Bioscience CEO Oliver Peoples to Present at the Advanced Bioeconomy Leadership Conference on April 3, 2019
WOBURN, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food industries, today announced that Oliver Peoples, Ph.D., president and chief executive officer of Yield10 will present at the Advanced Bioeconomy Leadership Conference (ABLC) 2019 held April 3-5 at the Mayflower Marriott Hotel in Washington, D.C.
Dr. Peoples’ presentation is titled “The Yield10 Trait Factory: Deploying Knowledge Gained from Industrial Biotech with Genome-editing to Increase Crop Yield” and will take place on the ABLC Advanced Nutrition & Bioeconomy Feedstocks and Supply Chain track in a panel entitled “Advanced Yields through Technology” on Wednesday April 3, 2019 at 12:40 p.m. Eastern Time.
Dr. Peoples will describe the approaches Yield10 is taking to increase seed yield, oil content and biomass in crops. He will also highlight the Company’s GRAIN technology platform and provide an overview of traits in development by Yield10, including traits potentially accessible through genome-editing and applicable to major crops including canola, corn, soybean, wheat and rice.
The ABLC conference hosts professionals in policy, finance, partnerships, world class R&D and effective scale-up, spanning major agricultural companies, heads of all the top agricultural trade associations, and key government agencies. The keynote speaker is Hon. Sonny Perdue, the 31st US Secretary of Agriculture. Learn more about the conference at the Advanced Bioeconomy Leadership Conference 2019 website. Following the presentation, a copy of Dr. Peoples’ slide deck will be available on the Yield10 Bioscience website.
About Yield10 Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food industries to achieve step-change improvements in crop yield to enhance global food security. Yield10 has an extensive track record of innovation based around optimizing the flow of carbon in living systems. The “Trait Factory” has two components: the “GRAIN” computational modeling platform, which is used to identify specific gene changes designed to improve crop performance, and the deployment of those changes into crops using genome-editing or traditional agricultural biotechnology approaches. The purpose of the “Trait Factory” is to engineer precise alterations to gene activity and the flow of carbon in plants to produce higher yields with lower inputs of land, water or fertilizer. Yield10 is advancing several yield traits it has developed in crops such as canola, soybean, rice, wheat and corn. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada.
For more information about the company, please visit www.yield10bio.com.
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical, including, without limitation, the use of the Company’s technology to successfully identify targets and develop systems for increasing crop yield and the progress toward developing yield traits in crops by Yield10, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including the risks and uncertainties detailed in Yield10 Bioscience’s filings with the Securities and Exchange Commission. Yield10 assumes no obligation to update any forward-looking information contained in this press release or with respect to the matters described herein.
Contacts: Yield10 Bioscience: Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations: Bret Shapiro, 561-479-8566, email@example.com Managing Director, CORE IR
Media Inquiries: Eric Fischgrund, firstname.lastname@example.org FischTank Marketing and PR